1988
DOI: 10.1016/0020-7519(88)90008-2
|View full text |Cite
|
Sign up to set email alerts
|

Immunization of cattle against theileriosis using varying doses of Theileria parva lawrencei and T. parva parva sporozoites and oxytetracycline treatments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

1991
1991
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 17 publications
0
13
0
Order By: Relevance
“…The treatment costs have been estimated to be as high as Kshs. 200-400 per treatment (Mutugi et al, 1988;Young et al, 1988;Young et al, 1989;Young et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…The treatment costs have been estimated to be as high as Kshs. 200-400 per treatment (Mutugi et al, 1988;Young et al, 1988;Young et al, 1989;Young et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…Great difficulties are currently being encountered in using buffalo-derived T. p. lawrencei stocks in the infection-and-treatment immunisation since oxytetracycline treatment does not always prevent the development of clinical disease in immunised cattle (Mutugi et aL, 1988b). It would appear from a comparative study that buparvaquone treatment could be safer than oxytetracycline in the control of more virulent theilerial stocks (Mutugi et al, 1988a).…”
Section: Discussionmentioning
confidence: 98%
“…In a study where cattle were immunised against a virulent T. p. lawrencei parasite, buparvaquone controlled higher doses of this parasite stock (Mutugi et al, 1988a) better than both short-and long-acting oxytetracycline formulations as shown in a comparative immunisation study (Mutugi, Young, Maritim, Ndungu, Stagg, Grootenhuis and Leitch, 1988b) where the same parasite stock was used.…”
mentioning
confidence: 99%
“…that the animal experiences "immunization failure ". However, the outcome following infection with T. parva is dose-dependent (Dolan et al, 1984): a dose needs to be increased sufficiently to acquire infection (Mutugi et al, 1988), but increases the risk that an animal shows a severe reaction following immunization requiring additional treatment (and which may result in death), i.e. that the animal experiences "dysimmunization" (Marcotty et al, 2001).…”
Section: Introductionmentioning
confidence: 99%